Felip, E., & Rosell, R. (2008). Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC). Dove Medical Press.
Chicago Style aipamenaFelip, Enriqueta, and Rafael Rosell. Pemetrexed As Second-line Therapy for Advanced Non-small-cell Lung Cancer (NSCLC). Dove Medical Press, 2008.
MLA aipamenaFelip, Enriqueta, and Rafael Rosell. Pemetrexed As Second-line Therapy for Advanced Non-small-cell Lung Cancer (NSCLC). Dove Medical Press, 2008.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.